ADIAL PHARMACEUTICALS, INC. reports

Company location: Charlottesville, VA
Fiscal year end: 31 December

ADIAL PHARMACEUTICALS, INC. has filed 553 SEC EDGAR filings since 16 Mar 2011

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 226-250 of 553 matching filings.

Per page

Current page

S-8 File 333-267972

REGISTRATION STATEMENT

Filing date: 21 Oct 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 13 Oct 2022
Reporting date: 13 Oct 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 26 Sep 2022
Reporting date: 26 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4 filing

Filing date: 20 Sep 2022
Reporting date: 19 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 14 Sep 2022
Reporting date: 13 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 13 Sep 2022
Reporting date: 08 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 06 Sep 2022
Reporting date: 06 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 02 Sep 2022
Reporting date: 31 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEF 14A File 001-38323

DEFINITIVE PROXY STATEMENT

Filing date: 01 Sep 2022
Reporting date: 13 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 23 Aug 2022
Reporting date: 22 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 23 Aug 2022
Reporting date: 18 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4 filing

Filing date: 22 Aug 2022
Reporting date: 18 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 16 Aug 2022
Reporting date: 16 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38323

QUARTERLY REPORT

Filing date: 15 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 20 Jul 2022
Reporting date: 20 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

EFFECT File 333-229615

EFFECT filing

Filing date: 29 Jun 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-220368

EFFECT filing

Filing date: 29 Jun 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 28 Jun 2022
Reporting date: 27 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 27 Jun 2022
Reporting date: 27 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

POS AM File 333-220368

POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1

Filing date: 24 Jun 2022
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

POS AM File 333-229615

POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-1

Filing date: 24 Jun 2022
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38323

CURRENT REPORT

Filing date: 16 May 2022
Reporting date: 16 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38323

QUARTERLY REPORT

Filing date: 16 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B3 File 333-263037

PROSPECTUS SUPPLEMENT

Filing date: 12 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-263037

EFFECT filing

Filing date: 08 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing